What does the evidence say about Tocotrienols Skin Hydration Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Tocotrienols Skin Hydration Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Results According to the repeated-measures ANOVA, the control and study group had a significant reduction in follicular papule counts over time (all p Conclusion The combined formula effectively reduced follicular papules, improved skin hydration, decreased TEWL, and alleviated depressive symptoms in KP patients. [Liu F (2026); evidence level 2] - Objective Keratosis pilaris (KP) is a common follicular keratotic skin disorder characterized by follicular papules and skin roughness, often accompanied by itching and inflammation, significantly affecting appearance and psychological health. [Liu F (2026); evidence level 2] - Methods This 28-day prospective, open-label, randomized controlled study evaluated the effectiveness of a novel combined formula for KP treatment. [Liu F (2026); evidence level 2] - This research aims to investigate the efficacy of tocotrienol-rich fraction (TRF) on various health parameters associated with general well-being in individuals aged between 50 years and 75 years. [Amir Razak NAN (2025); evidence level 2] - Background Tocotrienol, a naturally occurring form of vitamin E, has been extensively studied for its potent antioxidant, anti-inflammatory, and immune-stimulating properties. [Amir Razak NAN (2025); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.